Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01108497 · ClinicalTrials.gov registry record
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 235
- Enrollment target
NCT01108497: Clinical Trial study, sponsored by Stanford University.
NCT01108497 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 235 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01108497 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 235 participants
- Enrollment target
Study Summary
We will study gene and protein expression in leukemia cells of children diagnosed with acute leukemia. We hope to identify genes or proteins which can help us grade leukemia at diagnosis in order to: (a) develop better means of diagnosis and (b) more accurately choose the best therapy for each patient.
Interventions
- PROCEDURE Bone Marrow Aspiration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2001-07 |
| Est. Completion | 2015-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01108497
The ClinicalTrials.gov registry entry for NCT01108497 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bone Marrow Aspiration is the first listed.
NCT01108497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01108497 about?
NCT01108497 is a clinical study titled "Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia". We will study gene and protein expression in leukemia cells of children diagnosed with acute leukemia. We hope to identify genes or proteins which can help us grade leukemia at diagnosis in order to: (a) develop better means of diagnosis and (b) more accurately choose the best therapy for each patie...
What is the current status of trial NCT01108497?
This trial is currently terminated. The enrollment target is 235 participants. The study started on 2001-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01108497?
The interventions under investigation include: Bone Marrow Aspiration (PROCEDURE).
Who is sponsoring clinical trial NCT01108497?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.